Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker DMAC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Trill AB 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 73,099 | $8.57 | $626.5K Buy | Form 4 ↗ |
| Nov 24, 2025 | Trill AB 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 40,253 | $7.89 | $317.6K Buy | Form 4 ↗ |
| Nov 21, 2025 | Trill AB 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 208,872 | $7.41 | $1.5M Buy | Form 4 ↗ |
| Nov 20, 2025 | Trill AB 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 128,426 | $7.41 | $951.6K Buy | Form 4 ↗ |
| Nov 19, 2025 | Trill AB 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 240,352 | $7.21 | $1.7M Buy | Form 4 ↗ |
| Nov 18, 2025 | Trill AB 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 182,882 | $6.75 | $1.2M Buy | Form 4 ↗ |
| Nov 17, 2025 | Trill AB 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 187,393 | $6.52 | $1.2M Buy | Form 4 ↗ |
| Aug 27, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 50,772 | $6.00 | $304.6K Buy | Form 4 ↗ |
| Aug 26, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 59,648 | $6.00 | $357.9K Buy | Form 4 ↗ |
| Aug 25, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 338,265 | $6.00 | $2.0M Buy | Form 4 ↗ |
| Aug 22, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 59,788 | $5.96 | $356.3K Buy | Form 4 ↗ |
| Aug 21, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 48,172 | $5.96 | $287.1K Buy | Form 4 ↗ |
| Aug 20, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 71,107 | $5.86 | $416.7K Buy | Form 4 ↗ |
| Aug 15, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 8,233 | $6.00 | $49.4K Buy | Form 4 ↗ |
| Aug 14, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 70,414 | $5.99 | $421.8K Buy | Form 4 ↗ |
| Aug 13, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 293,601 | $5.91 | $1.7M Buy | Form 4 ↗ |
| Jul 23, 2025 | Richard Jacinto II 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 400,000 | $3.50 | $1.4M Buy | Form 4 ↗ |
| Jul 23, 2025 | Jan Stahlberg 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 1.54M | $3.50 | $5.4M Buy | Form 4 ↗ |
| Jul 23, 2025 | Thomas Von Koch 10% owner | DMAC DiaMedica Therapeutics Inc. | Buy | 2.86M | $3.50 | $10.0M Buy | Form 4 ↗ |
19 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:45 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances